CSI Laboratories Introduces the e.MERGE Report™ And New, State-of-the-Art Headquarters
Thursday, September 08, 2011
Download PDF
CSI Laboratories announced today that it has achieved two major milestones: the introduction of the industry’s first, fully customizable e.MERGE Report and the opening of its new company headquarters.
e.MERGE Reporting™ is an easy-to-use, web-based system that allows pathologists to create an e.MERGE Report, a single-page consolidated patient summary. Accessible through the e.CSI™ client portal, this new system gives pathologists tremendous control over their information. Users merge CSI’s expertise with their morphologic assessment, branding, color images and final diagnosis. Pathologists now have the distinct advantage of providing the customized patient report that meets the needs of their clinicians. For a demonstration, visit CSI Laboratories in
Booth 517 at CAP’11.
“Today, many community pathologists find themselves losing business to large national laboratories. They can count on us to continue providing new products and services necessary to compete and grow their practices,” said Dr. Lawrence Hertzberg, CSI Laboratories’ Medical Director. “e.MERGE Reporting empowers pathologists to provide the summary report that their clinicians demand.”
CSI Laboratories also opened its new headquarters in a 65,000 square-foot building with large, light-filled spaces that offer an inviting work environment for the company’s 170 employees. CSI worked with Lord, Aeck & Sargent to design the new space with room to expand. Central to the new building is a state-of-the-art, 10,000 square-foot laboratory designed to improve workflow efficiencies and quality of analysis.
“CSI’s new headquarters is custom designed to support our high standards for quality, service and patient care. The facility provides us with the flexibility to add new technologies and services while creating an engaging work environment that will help us attract the industry’s greatest talents,” said Heather Creran, President and CEO. “Our investment in this new facility and e.MERGE Reporting are a testament to CSI’s ongoing commitment to support the pathology community.
About CSI Laboratories
CSI Laboratories is a specialized cancer diagnostic laboratory focused specifically on meeting the unique needs and challenges of pathologists and community hospitals. The company provides diagnostic testing in flow cytometry, cytogenetic analysis, fluorescence in-situ hybridization (FISH), immunohistochemistry, molecular genetics and consultations in the areas of hematopathology and surgical pathology. All of CSI’s testing services are performed in its CLIA-certified and CAP-accredited laboratory located in Alpharetta, GA. CSI Laboratories is independently owned and operated by medical professionals, and has provided expert diagnostic testing to physicians across the United States since 1997. For more information, please visit www.csilaboratories.com